Sustainability of diet-based moderate calorie restriction among obese patients with metabolic-associated fatty liver disease.

IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Hepatology Forum Pub Date : 2021-09-15 eCollection Date: 2021-09-01 DOI:10.14744/hf.2021.2021.0014
Hakan Guveli, Tugce Ozlu, Busra Ersoy Tasar, Emre Batuhan Kenger, Eda Kaya
{"title":"Sustainability of diet-based moderate calorie restriction among obese patients with metabolic-associated fatty liver disease.","authors":"Hakan Guveli, Tugce Ozlu, Busra Ersoy Tasar, Emre Batuhan Kenger, Eda Kaya","doi":"10.14744/hf.2021.2021.0014","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aim: </strong>The long-term sustainability of weight loss continues to be a subject of investigation. This study was designed to examine the effects of weight loss and the long-term sustainability of lifestyle modifications among obese patients with metabolic-associated fatty liver disease (MAFLD).</p><p><strong>Materials and methods: </strong>A total of 40 patients who were prescribed a hypocaloric diet (~500 calories reduction for each patient), and who were followed up for 12 weeks in 4 face-to-face interviews were enrolled in the study. The patients were contacted at the 36<sup>th</sup> month, and their current weight was recorded.</p><p><strong>Results: </strong>The mean weight at baseline of 87±13 kg decreased to 79±11 kg after 12 weeks of intervention (p<0.001). The mean weight at the 36<sup>th</sup> month did not significantly differ from that measured at the baseline (p=0.563). The mean controlled attenuation parameter decreased from 320±13 dB/m to 273±37 dB/m (p<0.001), while the median liver stiffness measurement decreased from 8.7 kPa (3.6-45.7 kPa) to 5.7 kPa (2.2-29.9 kPa) (p<0.001).</p><p><strong>Conclusion: </strong>Strict follow-up through nutritional consultation can help achieve weight loss in obese patients with MAFLD. However, for long-term results, the collaboration of nutritionists and gastroenterologists is essential to prevent weight regain.</p>","PeriodicalId":29722,"journal":{"name":"Hepatology Forum","volume":"2 3","pages":"97-101"},"PeriodicalIF":1.2000,"publicationDate":"2021-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ef/df/hf-2-97.PMC9138938.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatology Forum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/hf.2021.2021.0014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/9/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aim: The long-term sustainability of weight loss continues to be a subject of investigation. This study was designed to examine the effects of weight loss and the long-term sustainability of lifestyle modifications among obese patients with metabolic-associated fatty liver disease (MAFLD).

Materials and methods: A total of 40 patients who were prescribed a hypocaloric diet (~500 calories reduction for each patient), and who were followed up for 12 weeks in 4 face-to-face interviews were enrolled in the study. The patients were contacted at the 36th month, and their current weight was recorded.

Results: The mean weight at baseline of 87±13 kg decreased to 79±11 kg after 12 weeks of intervention (p<0.001). The mean weight at the 36th month did not significantly differ from that measured at the baseline (p=0.563). The mean controlled attenuation parameter decreased from 320±13 dB/m to 273±37 dB/m (p<0.001), while the median liver stiffness measurement decreased from 8.7 kPa (3.6-45.7 kPa) to 5.7 kPa (2.2-29.9 kPa) (p<0.001).

Conclusion: Strict follow-up through nutritional consultation can help achieve weight loss in obese patients with MAFLD. However, for long-term results, the collaboration of nutritionists and gastroenterologists is essential to prevent weight regain.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在患有代谢相关性脂肪肝的肥胖患者中开展基于饮食的适度卡路里限制的可持续性。
背景和目的:减肥的长期可持续性仍是一个研究课题。本研究旨在探讨代谢相关性脂肪肝(MAFLD)肥胖患者减肥的效果以及改变生活方式的长期可持续性:本研究共招募了 40 名接受低热量饮食治疗(每人减少约 500 卡路里)的患者,对他们进行了为期 12 周的随访,共进行了 4 次面对面访谈。在第 36 个月时与患者取得联系,记录他们目前的体重:结果:基线时的平均体重为 87±13 公斤,经过 12 周的干预后降至 79±11 公斤(第 36 个月与基线时的测量值无显著差异(P=0.563))。平均控制衰减参数从 320±13 dB/m 降至 273±37 dB/m(p 结论:通过营养咨询进行严格的随访可帮助肥胖的 MAFLD 患者减轻体重。然而,为了取得长期效果,营养学家和胃肠病学家的合作对于防止体重反弹至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.90
自引率
12.50%
发文量
0
期刊最新文献
Safety analysis of different ıntensities of elf-pemf in terms of apoptotic, inflammatory, and transcription factor NF-Κb expression levels in rat liver. An alternative method in the diagnosis of intrabiliary lesions: Percutaneous endobiliary brush biopsy. D-dimer is a prognostic marker for 1-year mortality in patients with chronic liver failure and hepatic encephalopathy. Intrabiliary pressure in the pathophysiology of extra hepatic biliary obstruction. Leflunomide induced fatal dress syndrome need liver transplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1